₹ 977.3
Key Takeaways
Risk factor
Negligible price volatility
Profitability factor
Very strong margins and returns
About
Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, Europe, Latin America, the Asia Pacific, and Africa. The company operates in Pharmaceuticals and Consumer Products segments. It offers finished dosage human formulations comprising generics, branded generics, and specialty formulations, including biosimilars and vaccines;...
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV
Target Price
The average target price of ZYDUSLIFE.NS is 1086 and suggests 11% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recomme
